Natriuretic Peptides/cGMP/cGMP-Dependent Protein Kinase Cascades Promote Muscle Mitochondrial Biogenesis and Prevent Obesity

Miyashita, Kazutoshi, Itoh, Hiroshi, Tsujimoto, Hirokazu, Tamura, Naohisa, Fukunaga, Yasutomo, Sone, Masakatsu, Yamahara, Kenichi, Taura, Daisuke +3 more·2009·Diabetes

Cited by (288)

Items 201–288 of 288

  1. Discovery of another mechanism for the inhibition of particulate guanylyl cyclases by the natriuretic peptide clearance receptor
    Dianxin Liu, Ryan P. Ceddia, Wei Zhang, Fubiao Shi, Huafeng Fang, Sheila Collins · 2023 · Proceedings of the National Academy of Sciences
  2. Examination of the brain natriuretic peptide rs198389 single-nucleotide polymorphism on type 2 diabetes mellitus and related phenotypes in an Algerian population
    Djabaria Naïma Meroufel, Hadjira Ouhaïbi-Djellouli, Sounnia Médiène-Benchekor, Xavier Hermant, Benjamin Grenier‐Boley, Sarah Aïcha Lardjam-Hetraf, Houssam Boulenouar, Imane Hamani-Medjaoui, Nadhira Saïdi‐Mehtar, Philippe Amouyel et al. · 2015 · Gene
  3. The association between N-terminal pro B-type natriuretic peptide and lipoprotein particle concentration plateaus at higher N-terminal pro B-type natriuretic peptide values: Multi-Ethnic Study on Atherosclerosis
    Otto Alexander Sanchez, Daniel A. Duprez, Lori B. Daniels, Alan S. Maisel, James D. Otvos, Carmen Alicia Peralta, João A.C. Lima, Hossein Bahrami, David R. Jacobs · 2015 · Metabolism
  4. Pharmacologic blockade of the natriuretic peptide clearance receptor promotes weight loss and enhances insulin sensitivity in type 2 diabetes
    Liming Wang, Yuping Tang, Mark A. Herman, Robert F. Spurney · 2022 · Translational research
  5. Corin Deficiency Alters Adipose Tissue Phenotype and Impairs Thermogenesis in Mice
    Xianrui Zhang, Wenguo Li, Tiantian Zhou, Meng Liu, Qingyu Wu, Ningzheng Dong · 2022 · Biology
  6. GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults
    Lara Cheslow, Matthew D. Byrne, Jessica S. Kopenhaver, Lorraine Iacovitti, Richard Jay Smeyne, Adam Eugene Snook, Scott Arthur Waldman · 2024 · npj Parkinson s Disease
  7. N-terminal pro-B-type natriuretic peptide level inversely associates with metabolic syndrome in elderly persons
    Ji‐Hung Wang, Chung‐Jen Lee, Jen‐Che Hsieh, Yu-Chih Chen, Bang‐Gee Hsu · 2014 · Diabetology & Metabolic Syndrome
  8. Cardiac Natriuretic Peptides: Contributors to Cardiac Cachexia or Possible Anti-obesity Agents or Both?
    Lisa C. Costello‐Boerrigter · 2012 · Diabetes
  9. Natriuretic peptides in children
    Anne Lenz · 2011 · Current Opinion in Pediatrics
  10. Involvement of natriuretic peptide system in C2C12 myocytes
    Kiyoshi Ishikawa, Taiki Hara, Kana Kato, Takeshi Shimomura, Kenji Omori · 2018 · Molecular and Cellular Biochemistry
  11. Paradoxical Clearance of Natriuretic Peptide between Pulmonary and Systemic Circulation: A Pulmonary Mechanism of Maintaining Natriuretic Peptide Plasma Concentration in Obese Individuals
    Taro Date, Teiichi Yamane, Seigo Yamashita, Seiichiro Matsuo, Masato Matsushima, Keiichi Inada, Ikuo Taniguchi, Michihiro Yoshimura · 2011 · The Journal of Clinical Endocrinology & Metabolism
  12. Body Composition Measures and N-terminal pro-B-type Natriuretic Peptide (NT-pro-BNP) in US Adults
    Justin Basile Echouffo-Tcheugui, Sui Zhang, John William McEvoy, Stephen Paul Juraschek, Josef Coresh, Robert H. Christenson, Chiadi E. Ndumele, Elizabeth Selvin · 2023 · Clinical Chemistry
  13. Regulatory role of atrial natriuretic peptide in brown adipose tissue: A narrative review
    Guanhua Lu, Ruixiang Hu, Tao Tian, Min Hu, Zhiyong Dong, Cunchuan Wang · 2022 · Obesity Reviews
  14. Fatty Liver Is Associated with Low N-Terminal Pro-B-Type Natriuretic Peptide in a Healthy Population
    Hyo‐In Choi, Mi Yeon Lee, Byeong Kil Oh, Seung Jae Lee, Jeonggyu Kang, Sung Ho Lee, Jong‐Young Lee, Byung Jin Kim, Bum Soo Kim, Jin Ho Kang et al. · 2021 · Journal of Clinical Medicine
  15. Metabolism of Natriuretic peptides and impact on insulin resistance and fat mass in healthy subjects
    Timothy C. R. Prickett, Lynley K. Lewis, John F. Pearson, Eric Arnold Espiner · 2025 · Clinical Biochemistry
  16. The natriuretic peptide system as a possible therapeutic target for stress-induced obesity
    Jochen Mutschler, Falk Kiefer · 2010 · Medical Hypotheses
  17. Bioactivity of Red Sea Algae for Industrial Application and Biomedical Engineering
    Hiba Mohammed, Asmaa Sayed Abdelgeliel, Andrea Cochis, W. F. Sayed, Lia Rimondini · 2019 · Springer series in biomaterials science and engineering
  18. Heart Failure in Diabetes Mellitus: An Updated Review
    Catrin Sohrabi, Bunny Saberwal, Wei Yao Lim, Dimitris Tousoulis, Syed Ahsan, Νικόλαος Παπαγεωργίου · 2020 · Current Pharmaceutical Design
  19. Close Linkage Between Natriuretic Peptides and Obesity ― Impact of Sex on the Interorgan Metabolic Crosstalk ―
    Tomohisa Nagoshi · 2021 · Circulation Journal
  20. Association of natriuretic peptides and receptor activity with cardio-metabolic health at middle age
    Timothy C. R. Prickett, Eric Arnold Espiner, John F. Pearson · 2024 · Scientific Reports
  21. Sex-based differences in metabolic protection by the ANP genetic variant rs5068 in the general population
    Tomoko Ichiki, Valentina Cannone, Christopher G. Scott, Seethalakshmi R. Iyer, S. Jeson Sangaralingham, Kent R. Bailey, Jens Peter Goetze, Yoshihisa Tsuji, Richard J. Rodeheffer, John C. Jr Burnett · 2023 · American Journal of Physiology-Heart and Circulatory Physiology
  22. Relative B-Type Natriuretic Peptide Deficiency May Exist in Diastolic Dysfunction in Subclinical Population
    Chisato Okamoto, Osamu Tsukamoto, Takuya Hasegawa, Ken Matsuoka, Makoto Amaki, Hideaki Kanzaki, Chisato Izumi, Seiji Takashima, Shin Ito, Masafumi Kitakaze · 2024 · Circulation Reports
  23. ANP-ing Up Diabetes: Impaired Natriuretic Peptide Action in Muscle Forms a Mechanistic Link Between Obesity and Diabetes
    Mark E. Cleasby · 2015 · Diabetes
  24. cGMP manipulation in cardiometabolic disease
    Jens Jordan, Staffan Hildebrand, Alexander Pfeifer · 2019 · Current Opinion in Cardiology
  25. The influence of metabolic syndrome and diabetes mellitus on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with coronary artery disease
    Fang‐Yang Huang, Yong Peng, Xuexue Deng, Bao‐Tao Huang, Tianli Xia, Yi-Yue Gui, Rui-Shuang Liu, Yong Yang, Xiaobo Pu, Shi-Jian Chen et al. · 2016 · Coronary Artery Disease
  26. Six‐year changes in N‐terminal pro‐brain natriuretic peptide and changes in weight and risk of obesity
    Mariana Sbaraini da Silva, Mariana Lazo, Natalie Rula Daya, Olive Tang, Beatriz D'Agord Schaan, Christie Mitchell Ballantyne, Chiadi E. Ndumele, Elizabeth Selvin · 2021 · Obesity
  27. Natriuretic peptides increase cGMP around cardiomyocyte mitochondria and protect against apoptosis
    Gaia Calamera, Bernadin Ndongson‐Dongmo, Dulasi Arunthavarajah, Mette Ovesen, Jeong Joo Kim, Choel Kim, Kjetil Wessel Andressen, Lise Román Moltzau · 2022 · Journal of Molecular and Cellular Cardiology
  28. Blunted increase in plasma BNP during acute coronary syndrome attacks in obese patients
    Toraaki Okuyama, Tomohisa Nagoshi, Nana Hiraki, Toshikazu D. Tanaka, Yuhei Oi, Haruka Kimura, Yusuke Kashiwagi, Kazuo Ogawa, Kosuke Minai, Takayuki Ogawa et al. · 2024 · IJC Heart & Vasculature
  29. Natriuretic peptide signaling is involved in the expression of oxidative metabolism-related and muscle fiber constitutive genes in the gastrocnemius muscle
    Kiyoshi Ishikawa, Taiki Hara, Mao Mizukawa, Yasufumi Fukano, Takeshi Shimomura · 2019 · Molecular and Cellular Endocrinology
  30. Prognostic Value of Novel Natriuretic Peptide Index After Percutaneous Coronary Intervention
    Takeo Horikoshi, Takamitsu Nakamura, Kazuyuki Yamaguchi, Toru Yoshizaki, Yosuke Watanabe, Kenji Kuroki, Manabu Uematsu, Kazuto Nakamura, Tsuyoshi Kobayashi, Akira Sato · 2022 · Circulation Journal
  31. Pre-IVM with C-type natriuretic peptide promotes mitochondrial biogenesis of bovine oocytes via activation of CREB
    Zehua Zhang, Zhenwei Jia · 2024 · Scientific Reports
  32. Role of cGMP in fat and metabolism
    Alexander Pfeifer, Ana Kilić, Linda Sarah Hoffmann · 2013 · BMC Pharmacology and Toxicology
  33. Statin treatment is associated with a negative correlation between NT-proBNP and insulin resistance in patients without history of heart failure
    Jun‐Sing Wang, Chia-Lin Lee, Wen‐Jane Lee, I‐Te Lee, Shih‐Yi Lin, Wen-Lieng Lee, Kae‐Woei Liang, Wayne Huey‐Herng Sheu · 2016 · Clinica Chimica Acta
  34. Correlación de los niveles plasmáticos del péptido natriurético tipo B con marcadores de riesgo metabólico
    José Armando Ahued-Ortega, Plácido Enrique León-García, Elizabeth Hernández‐Pérez · 2018 · Medicina Clínica
  35. Correlation of plasma B-type natriuretic peptide levels with metabolic risk markers
    José Armando Ahued-Ortega, Plácido Enrique León-García, Elizabeth Hernández‐Pérez · 2018 · Medicina Clínica (English Edition)
  36. Natriuretic peptides in the cross-talk of human cardiovascular and metabolic regulation
    Jens Jordan, Guido M. Grassi · 2015 · Journal of Hypertension
  37. Impact of Left Ventricular Assist Device on Diabetes Management: An Evaluation through Case Analysis and Clinical Impact
    Angela R. Subauste, Nazanene Helen Esfandiari, Yunyan Qu, Elif A Oral, Keith D. Aaronson, Francis D. Pagani, Roma Yogesh Gianchandani · 2014 · Hospital Practice
  38. Levels of N‐terminal pro brain natriuretic peptide are enhanced in people with the uncomplicated metabolic syndrome: a case‐cohort analysis of the population‐based Casale Monferrato study
    Graziella Bruno, Federica Barutta, Andrea Landi, Silvia Pinach, Paola Caropreso, Giulio Mengozzi, Stefano Baldassarre, Salvatore Fragapani, Stefania Civera, Paolo Cavallo Perin et al. · 2014 · Diabetes/Metabolism Research and Reviews
  39. Association of fat mass profile with natriuretic peptide receptor alpha in subcutaneous adipose tissue of medication-free healthy men: A cross-sectional study
    Petros C. Dinas, Eleni Nintou, Dimitra Psychou, Marnie Granzotto, Marco Rossato, Roberto Vettor, Athanasios Z. Jamurtas, Yiannis Koutedakis, George S. Metsios, Andreas D. Flouris · 2018 · F1000Research
  40. Heart Hormones
    Ayano Chiba, Naoki Mochizuki · 2019 · Elsevier eBooks
  41. Diabetes Mellitus, Natriuretic Peptide Axis Dysregulation, and Diabetic Cardiomyopathy
    Burkert Mathias Pieske, Elisabeth Kraigher‐Krainer · 2010 · European Journal of Heart Failure
  42. Relationship between lipid profile and B‑type natriuretic peptide T‑381C (rs198389) gene polymorphism in patients with stable coronary artery disease
    Gawhar Ahmed Shekha, Kalthum Asaaf Maulood, Mudhir Sabir Shekha · 2023 · Cellular and Molecular Biology
  43. Exercise performance is not improved in mice with skeletal muscle deletion of natriuretic peptide clearance receptor
    Brigitte Jia, Alexander Hasse, Fubiao Shi, Sheila Collins · 2023 · PLoS ONE
  44. N-terminal Pro-B-Type Natriuretic Peptide and Risk for Diabetes Mellitus and Metabolic Syndrome
    Charles D Nicoli, D. Leann Long, Timothy B. Plante, Suzanne E. Judd, Leslie Ain McClure, April P. Carson, Mary Cushman · 2024 · The Journal of Clinical Endocrinology & Metabolism
  45. Adenosine Receptor Transcriptomic Profile in Cardiac Tissue of a Zucker Rat Model
    Manuela Cabiati, B. Svezia, Maria Angela Guzzardi, Letizia Mattii, Andrea D’Amico, Chiara Caselli, Tommaso Prescimone, Maria Aurora Morales, Silvia Del Ry · 2015 · DNA and Cell Biology
  46. A Role for Natriuretic Peptides in the Central Control of Energy Balance?
    Kathryn E. Berkseth, Ellen A. Schur, Michael W. Schwartz · 2013 · Diabetes
  47. Natriuretic peptides in heart failure
    Kimberly D Tran, Niraj Parekh, Alan S. Maisel · 2010 · Therapy
  48. Autism, Sleep Disordered Breathing, and Intracranial Hypertension: The Circumstantial Evidence
    Deborah Wardly · 2014
  49. CLINICAL SIGNIFICANCE OF NATRIURETIC PEPTIDES (review)
    Larysa Zhuravlyova, Неля Сокольнікова, Tetyana Rogachova · 2022 · Inter Collegas
  50. Human adipose tissue expression of uncoupling protein 1 in response to intravenous administration of B‐type natriuretic peptide hormone: Results from a randomized controlled crossover study
    Katherine N. Bachmann, Ryan P. Ceddia, Deepak K. Gupta, Sheila Collins, Thomas J. Wang · 2024 · Diabetes Obesity and Metabolism
  51. Molecular insights into the corin function at the uteroplacental interface
    Ningzheng Dong, Meirong Du, Qingyu Wu · 2025 · Placenta
  52. Regulation, effects and monitoring of compartmented cGMP signalling in cardiomyocytes—current status
    Kjetil Wessel Andressen, Daiana Sedneva‐Lugovets, Mette Ovesen, Ana Isabel Calejo, Dulasi Arunthavarajah, Finn Olav Levy · 2025 · British Journal of Pharmacology
  53. Contrôle du métabolisme énergétique par les peptides natriurétiques
    Cédric Moro · 2013 · médecine/sciences
  54. Brain Natriuretic Peptide Counteracting the Renin-angiotensin-aldosterone System in Accelerated Malignant Hypertension
    Hitoshi Nakagawa, Yuji Mizuno, Eisaku Harada, Yoshinobu Morikawa, Koichiro Kuwahara, Yoshihiko Saito, Hirofumi Yasue · 2016 · The American Journal of the Medical Sciences
  55. Cardiac Natriuretic Peptide System: A Link between Adipose Tissue, Obesity, and Insulin Resistance
    Mustafa Öztop · 2022 · IntechOpen eBooks
  56. Effects of angiotensin receptor-neprilysin inhibitor on ketone body metabolism in pre-heart failure/heart failure patients
    Yusuke Kashiwagi, Tomohisa Nagoshi, Yoshiro Tanaka, Yuhei Oi, Haruka Kimura, Kazuo Ogawa, Makoto Kawai, Michihiro Yoshimura · 2024 · Scientific Reports
  57. The role of natriuretic peptides in regulation of cardiovascular system
    V. Khirmanov · 2017 · Russian Journal of Cardiology and Cardiovascular Surgery
  58. alteration of renal natriuretic Systems is associated with the development of Hypertension and Precedes the Presence of renal damage in a Model of Metabolic Syndrome
    Natalia L. Rukavina Mikusic, Nicolás Martín Kouyoumdzian, Julieta Sofía Del Mauro, Mariela Mercedes Gironacci, Ana M. Puyó, Jorge E. Tobbli, Belisario Enrique Fernández, Marcelo R. Choi · 2018 · Revista Argentina de Cardiología
  59. Association between Elevated N-Terminal Pro-Brain Natriuretic Peptide and Cardiovascular Complication among Type-2 Diabetic Patients in Gaza Strip
    Faten Allyan, MohamedA. Adris, Baker M. Zabut, Mustafa Aa · 2019 · Clinical Research Open Access
  60. Functional analysis of the brain natriuretic peptide gene for high-altitude adaptation in Tibetan pigs
    Xiaolong Tian, Jun Ma, Yijing Wu, Pan Zhang, Qinggang Li, Hao Zhang, Changxin Wu · 2020 · Gene
  61. A Defined α‐Helix in the Bifunctional O‐Glycosylated Natriuretic Peptide TcNPa from the Venom of Tropidechis carinatus
    Timothy Reeks, Alun Jones, Andreas Brust, Sindhuja Sridharan, Leo Corcilius, Brendan L. Wilkinson, Morten Thaysen‐Andersen, Richard J. Payne, R. Manjunatha Kini, Norelle L. Daly et al. · 2015 · Angewandte Chemie
  62. Comment on: Lazo et al. NH2-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes. Diabetes 2013;62:3189–3193
    Cédric Moro, Jens Jordan, Andreas L. Birkenfeld · 2013 · Diabetes
  63. Fatty Liver is Associated with Low N-terminal pro-B-type Natriuretic Peptide in a Healthy Population: From the Kangbuk Samsung Health Study
    Hyo‐In Choi, Mi Yeon Lee, Byeong Kil Oh, Seung Jae Lee, Jeonggyu Kang, Sung Ho Lee, Jong‐Young Lee, Byung Jin Kim, Bum Soo Kim, Jin Ho Kang et al. · 2021 · Research Square
  64. Estrogen withdrawal and liver fat accumulation : contribution of hepatic VLDL-TG production and effect of exercise training
    R. Barsalani · 2010
  65. The role of natriuretic peptides in the regulation of energy metabolism, lipid- and glucose homeostasis
    Andreas L. Birkenfeld · 2013 · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver
  66. Physiology and clinical importance of the natriuretic peptide system
    Gábor Viktor Szabó, János Rigó, Bálint Nagy · 2011 · Orvosi Hetilap
  67. 2. Treatment of Complicated Hypertension. 1) Antihypertensive Therapy in the Patient with Diabetes Mellitus or Metabolic Syndrome.
    Kazutoshi Miyashita, Hiroshi Itoh · 2011 · Nihon Naika Gakkai Zasshi
  68. Internal Medicine-Our Mission and Challenge
    Kazuwa Nakao · 2012 · Nihon Naika Gakkai Zasshi
  69. RELAÇÕES ENTRE MEDIDAS ANTROPOMÉTRICAS, PEPTÍDEO NATRIURÉTICO TIPO B E MORTALIDADE EM DEZ ANOS DE IDOSOS DO ESTUDO DE BAMBUÍ SOBRE
    Saúde E Envelhecimento · 2012
  70. Novel Role of CD47 in Obesity-Associated Metabolic Dysfunctions
    Heather Norman‐Burgdolf · 2016 · UKnowledge (University of Kentucky)
  71. Endocrine regulation of lipid mobilization in human obesity
    Verboven · 2017
  72. Adipose tissue metabolism and cardiometabolic health in obesity
    Stinkens · 2017
  73. A hipertóniától a szívelégtelenségig
    Klara Magyar, László Deres, Roland Gál, Ádám Riba, Tamás Habon, Kálmán Tóth, Róbert Halmosi · 2017 · Cardiologia Hungarica
  74. Overview of the Cross-Talk Between Hormones and Mitochondria
    Béatrice Morio, François Casas, Luc Pénicaud · 2019 · Elsevier eBooks
  75. Les peptides natriurétiques : une cible potentielle dans le diabète de type 2 ?
    D. Carper, Cédric Moro · 2019 · Médecine des Maladies Métaboliques
  76. Relações entre medidas antropométricas, peptídeo natriurético tipo B e mortalidade em dez anos de idosos do estudo de Bambuí sobre saúde e envelhecimento
    Alline Maria R. Beleigoli · 2012 · Americanae (AECID Library)
  77. New Care and Aging Dynamics in China
    Jason L. Powell · 2019 · Clinical Research Open Access
  78. Mechanism by which Heart Regulates Peripheral Metabolism in Obesity
    Monolina Habib Binny · 2014 · Digital WPI
  79. Contrôle du métabolisme oxydatif musculaire par les peptides natriurétiques
    Cédric Moro · 2021 · médecine/sciences
  80. Current literature in diabetes
    2010 · Diabetes/Metabolism Research and Reviews
  81. BNP protects against diabetic cardiomyopathy by promoting Opa1-mediated mitochondrial fusion via activating the PKG-STAT3 pathway
    Feng Fu, Pan Chang, Xiaomeng Zhang, Jing Zhang, Jianbang Wang, Xihui Wang, Man Li, Rui Wang, Jun Yu · 2022 · Research Square
  82. Serum N‐Terminal Pro‐B‐Type Natriuretic Peptide Is Associated With Insulin Resistance in Chinese: Danyang Study
    Ziwen Zheng, Junya Liang, Yun Gao, Mulian Hua, Siqi Zhang, Ming Liu, Zhuyuan Fang · 2024 · Journal of Clinical Hypertension
  83. Improvement of insulin sensitivity through hormone-sensitive lipase inhibition : study of the mechanisms involved
    Pauline Morigny · 2017 · theses.fr (ABES)
  84. Phosphodiesterases des nucleotides cycliques (pdes), stress oxydant et dysfonctions mitochondriales musculaires squelettiques au cours de l’ischemie-reperfusion
    Liliane Tetsi · 2019
  85. Selective targeting phosphodiesterase-5 (PDE5): clinical progress, design strategies, and emerging prospects
    Yanhong Li, Y Y Ma, Jingkao Chen, Bei Zhang, Peiliang Zhao · 2026 · Journal of Enzyme Inhibition and Medicinal Chemistry
  86. Natriuretic peptide receptor C in cardiovascular–kidney–liver–metabolic syndrome: from natriuretic peptide deficiency to direct tissue signaling?
    Matteo Landolfo, Francesco Spannella, C. Salva, Bernhard Radlinger, Susanne Kaser, Alessandro Gezzi, Riccardo Sarzani · 2026 · Reviews in Endocrine and Metabolic Disorders
  87. Rationale and design of the atrial natriuretic peptide and regulation of cardiometabolic health: a genotype-guided human physiological study (GENESIS)
    Harshvir Singh Bal, Akhil Pampana, Prabhat Ranjan, Amrita Nayak, Krishin Yerabolu, Hevi Patel, Nehal Vekariya, Michael R. Crowley, Peng Li, Garima Arora et al. · 2026 · American Journal of Preventive Cardiology
  88. Supraphysiological Testosterone Differentially Regulates Aortic Atheroma and Cardiac Remodelling in the Testicular Feminised Mouse
    Daniel M. Kelly, Joanne E. Nettleship, Marta M. Gillett, T. Hugh Jones · 2026 · Cells